Proquin XR Related Published Studies
Well-designed clinical trials related to Proquin XR (Ciprofloxacin)
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. [2009.08.01]
Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates. [2009.07]
A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery. [2009.07]
Effect of a Kampo preparation, byakkokaninjinto, on pharmacokinetics of ciprofloxacin and tetracycline. [2009.06]
Single Dose Azithromycin Versus Ciprofloxacin for Cholera in Children: A Randomized Controlled Trial. [2009.05.20]
A double-blind, placebo-controlled trial of ciprofloxacin prophylaxis in patients with acute necrotizing pancreatitis. [2009.04]
Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin. [2009.02]
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. [2009.01]
Comparative bioequivalence and pharmacokinetics of ciprofloxacin in healthy male subjects. [2009.01]
Clinical efficacy of intravenous ciprofloxacin in patients with biliary tract infection: a randomized controlled trial with carbapenem as comparator. [2009]
A Double-blind, Placebo-controlled Trial of Ciprofloxacin Prophylaxis in Patients with Acute Necrotizing Pancreatitis. [2008.12.11]
A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients. [2008.12]
Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*. [2008.12]
Effect of ciprofloxacin and ibuprofen on the in vitro metabolism of rosiglitazone and oral pharmacokinetics of rosiglitazone in healthy human volunteers. [2008.10]
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled pilot study. [2008.07.30]
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. [2008.07]
Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC. [2008.07]
Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. [2008.05]
Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial. [2008.03]
Ciprofloxacin and furagin in acute cystitis: comparison of early immune and microbiological results. [2008.02]
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. [2008.01]
Pharmacokinetics of topically applied ciprofloxacin in equine tears. [2007.11]
Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin. [2007.11]
A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. [2007.11]
Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy. [2007.10]
Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics. [2007.10]
Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers. [2007.09]
Bioequivalence of ciprofloxacin tablet formulations assessed in Indonesian volunteers. [2007.06]
A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. [2007.05]
Role of ciprofloxacin in patients with cholestasis after endoscopic retrograde cholangiopancreatography. [2007.01.14]
Effect of Five Alive fruit juice on the dissolution and absorption profiles of ciprofloxacin. [2007.01]
Effects of paracetamol on the pharmacokinetics of ciprofloxacin in plasma using a microbiological assay. [2007]
Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose. [2006.11]
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. [2006.11]
One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. [2006.11]
Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. [2006.09]
Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections. [2006.08]
Effectiveness of ciprofloxacin prophylaxis in preventing bacteriuria caused by urodynamic study: a blind, randomized study of 192 patients. [2006.06]
A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. [2006.06]
Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin. [2006.04.01]
Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa. [2006.04]
Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. [2006.02]
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. [2006.01.01]
Pharmacokinetics of ciprofloxacin XR (1000mg) versus levofloxacin (500mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose. [2006.01]
Oral ciprofloxacin affects the pharmacokinetics of paracetamol in saliva. [2006]
Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers. [2005.11]
Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. [2005.09.24]
Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. [2005.08.15]
Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. [2005.08]
Single-dose oral ciprofloxacin compared with single-dose intravenous cefazolin for prophylaxis in inguinal hernia repair: a controlled randomized clinical study. [2005.08]
Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers. [2005.07]
Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen. [2005.07]
The role of ciprofloxacin in prolonging polyethylene biliary stent patency: a multicenter, double-blinded effectiveness study. [2005.04]
Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances. [2005.04]
Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. [2005.03]
Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. [2005.02.23]
Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections. [2005]
Well-designed clinical trials possibly related to Proquin XR (Ciprofloxacin)
Randomized controlled trial of oral vs intravenous therapy for the clinically diagnosed acute uncomplicated diverticulitis. [2009.11]
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. [2009.08.20]
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days). [2009.08.19]
Effect of dietary protein level on growth performance, indicators of enteric health, and gastrointestinal microbial ecology of weaned pigs induced with postweaning colibacillosis. [2009.08]
Raxibacumab for the treatment of inhalational anthrax. [2009.07.09]
Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study. [2009.07]
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2009.07]
Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study. [2009.06]
A 12-year clinical evaluation of a three-step dentin adhesive in noncarious cervical lesions. [2009.05]
Green banana reduces clinical severity of childhood shigellosis: a double-blind, randomized, controlled clinical trial. [2009.05]
Conservative management of acute appendicitis. [2009.05]
Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. [2009.04]
Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study. [2009.04]
Pharmacokinetics of levetiracetam XR 500mg tablets. [2009.04]
Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes. [2009.04]
Antibiotic prophylaxis at urinary catheter removal prevents urinary tract infections: a prospective randomized trial. [2009.04]
One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy. [2009.04]
Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects. [2009.03]
Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. [2009.03]
The outcome of non-typhoidal salmonella meningitis in Malawian children, 1997-2006. [2009.03]
[Short or long schemes of antibiotic prophylaxis for prostate biopsy. A multicentre prospective randomised study.] [2009.01]
Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. [2009]
A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas. [2008.10]
Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy. [2008.10]
Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. [2008.09]
Extended-Release Metformin Does Not Reduce the Clomiphene Citrate Dose Required to Induce Ovulation in Polycystic Ovary Syndrome. [2008.08]
Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian aboriginal children with recently treated chronic suppurative otitis media: a randomized controlled trial. [2008.08]
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2008.07.17]
Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. [2008.07]
Oral vs intravenous antibiotic prophylaxis in elective laparoscopic cholecystectomy: an exploratory trial. [2008.07]
Validation of a reversed-phase high-performance liquid chromatography method with fluorescence detection for the bioequivalence study of norfloxacin in plasma samples. [2008.06]
Does disposable needle guide minimize infectious complications after transrectal prostate needle biopsy? [2008.06]
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. [2008.06]
A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. [2008.05.21]
Effect of the Antidepressant Venlafaxine in Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial. [2008.04.17]
An investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteers. [2008.03]
Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. [2008.03]
Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial. [2008.03]
Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study. [2008.02.11]
Pharmacokinetic-pharmacodynamic integration of orbifloxacin in rabbits after intravenous, subcutaneous and intramuscular administration. [2008.02]
Early treatment response in alcohol dependence with extended-release naltrexone. [2008.02]
Is surface roughness of resin composites affected by operator's performance? [2008.02]
Fracture resistance of endodontically treated teeth restored with combined composite-amalgam restorations. [2008.02]
Fluoroquinolones for treating tuberculosis. [2008.01.23]
|
